CN105996050A - 用于改善肠胃功能的乳酸菌制剂及制备方法 - Google Patents
用于改善肠胃功能的乳酸菌制剂及制备方法 Download PDFInfo
- Publication number
- CN105996050A CN105996050A CN201610312048.5A CN201610312048A CN105996050A CN 105996050 A CN105996050 A CN 105996050A CN 201610312048 A CN201610312048 A CN 201610312048A CN 105996050 A CN105996050 A CN 105996050A
- Authority
- CN
- China
- Prior art keywords
- preparation
- lactobacillus
- parts
- radix
- dry powder
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 238000002360 preparation method Methods 0.000 title claims abstract description 76
- 241000894006 Bacteria Species 0.000 title claims abstract description 28
- 230000007661 gastrointestinal function Effects 0.000 title claims abstract description 20
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 title abstract description 10
- 235000014655 lactic acid Nutrition 0.000 title abstract description 5
- 239000004310 lactic acid Substances 0.000 title abstract description 5
- 239000000843 powder Substances 0.000 claims abstract description 48
- 150000004676 glycans Chemical class 0.000 claims abstract description 42
- 229920001282 polysaccharide Polymers 0.000 claims abstract description 42
- 239000005017 polysaccharide Substances 0.000 claims abstract description 42
- PYMYPHUHKUWMLA-WDCZJNDASA-N arabinose Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)C=O PYMYPHUHKUWMLA-WDCZJNDASA-N 0.000 claims abstract description 21
- PYMYPHUHKUWMLA-UHFFFAOYSA-N arabinose Natural products OCC(O)C(O)C(O)C=O PYMYPHUHKUWMLA-UHFFFAOYSA-N 0.000 claims abstract description 21
- SRBFZHDQGSBBOR-UHFFFAOYSA-N beta-D-Pyranose-Lyxose Natural products OC1COC(O)C(O)C1O SRBFZHDQGSBBOR-UHFFFAOYSA-N 0.000 claims abstract description 21
- 229920002472 Starch Polymers 0.000 claims abstract description 19
- 239000010902 straw Substances 0.000 claims abstract 2
- 241000186660 Lactobacillus Species 0.000 claims description 77
- 229940039696 lactobacillus Drugs 0.000 claims description 77
- 241000195474 Sargassum Species 0.000 claims description 41
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 36
- 239000000463 material Substances 0.000 claims description 28
- 238000000855 fermentation Methods 0.000 claims description 23
- 230000004151 fermentation Effects 0.000 claims description 23
- 239000007788 liquid Substances 0.000 claims description 22
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 20
- 239000012153 distilled water Substances 0.000 claims description 19
- 239000003795 chemical substances by application Substances 0.000 claims description 18
- 239000002994 raw material Substances 0.000 claims description 15
- 239000008107 starch Substances 0.000 claims description 15
- 235000019698 starch Nutrition 0.000 claims description 15
- 239000002775 capsule Substances 0.000 claims description 14
- 235000015140 cultured milk Nutrition 0.000 claims description 14
- 238000001035 drying Methods 0.000 claims description 14
- 238000000108 ultra-filtration Methods 0.000 claims description 14
- 150000001875 compounds Chemical class 0.000 claims description 12
- 229960000935 dehydrated alcohol Drugs 0.000 claims description 11
- 238000007598 dipping method Methods 0.000 claims description 11
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims description 10
- 241000186016 Bifidobacterium bifidum Species 0.000 claims description 9
- 239000000203 mixture Substances 0.000 claims description 9
- 238000004321 preservation Methods 0.000 claims description 9
- 229930006000 Sucrose Natural products 0.000 claims description 8
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 claims description 8
- 238000003756 stirring Methods 0.000 claims description 8
- 239000000126 substance Substances 0.000 claims description 8
- 241000143437 Aciculosporium take Species 0.000 claims description 7
- 239000001913 cellulose Substances 0.000 claims description 7
- 229920002678 cellulose Polymers 0.000 claims description 7
- 239000002131 composite material Substances 0.000 claims description 7
- 229960004756 ethanol Drugs 0.000 claims description 7
- 238000001914 filtration Methods 0.000 claims description 7
- 238000007710 freezing Methods 0.000 claims description 7
- 230000008014 freezing Effects 0.000 claims description 7
- 239000012535 impurity Substances 0.000 claims description 7
- 239000012528 membrane Substances 0.000 claims description 7
- 235000013336 milk Nutrition 0.000 claims description 7
- 239000008267 milk Substances 0.000 claims description 7
- 210000004080 milk Anatomy 0.000 claims description 7
- 238000002156 mixing Methods 0.000 claims description 7
- 239000013049 sediment Substances 0.000 claims description 7
- 150000003384 small molecules Chemical class 0.000 claims description 7
- 239000007921 spray Substances 0.000 claims description 7
- 229920001285 xanthan gum Polymers 0.000 claims description 7
- 239000000230 xanthan gum Substances 0.000 claims description 7
- 235000010493 xanthan gum Nutrition 0.000 claims description 7
- 229940082509 xanthan gum Drugs 0.000 claims description 7
- 244000199866 Lactobacillus casei Species 0.000 claims description 6
- 235000013958 Lactobacillus casei Nutrition 0.000 claims description 6
- 238000000605 extraction Methods 0.000 claims description 6
- 229940017800 lactobacillus casei Drugs 0.000 claims description 6
- 238000001816 cooling Methods 0.000 claims description 3
- 210000000582 semen Anatomy 0.000 claims description 2
- 239000004744 fabric Substances 0.000 claims 1
- 230000000694 effects Effects 0.000 abstract description 6
- 229940100445 wheat starch Drugs 0.000 abstract description 4
- 230000008901 benefit Effects 0.000 abstract description 3
- 230000036039 immunity Effects 0.000 abstract description 3
- 239000006041 probiotic Substances 0.000 abstract description 3
- 235000018291 probiotics Nutrition 0.000 abstract description 3
- 244000052616 bacterial pathogen Species 0.000 abstract description 2
- 244000223760 Cinnamomum zeylanicum Species 0.000 abstract 1
- 240000008620 Fagopyrum esculentum Species 0.000 abstract 1
- 235000009419 Fagopyrum esculentum Nutrition 0.000 abstract 1
- 235000017803 cinnamon Nutrition 0.000 abstract 1
- 230000002401 inhibitory effect Effects 0.000 abstract 1
- 239000000243 solution Substances 0.000 description 29
- 230000000968 intestinal effect Effects 0.000 description 10
- 241000222336 Ganoderma Species 0.000 description 6
- 241000318836 Pleurotus nebrodensis Species 0.000 description 6
- 230000006870 function Effects 0.000 description 6
- 239000011669 selenium Substances 0.000 description 6
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 description 5
- 239000002671 adjuvant Substances 0.000 description 5
- 238000003304 gavage Methods 0.000 description 5
- 229910052711 selenium Inorganic materials 0.000 description 5
- 206010010774 Constipation Diseases 0.000 description 4
- 239000008280 blood Substances 0.000 description 4
- 210000004369 blood Anatomy 0.000 description 4
- 210000004072 lung Anatomy 0.000 description 4
- 201000006549 dyspepsia Diseases 0.000 description 3
- 239000000796 flavoring agent Substances 0.000 description 3
- 235000019634 flavors Nutrition 0.000 description 3
- 238000000034 method Methods 0.000 description 3
- 230000000813 microbial effect Effects 0.000 description 3
- 210000002784 stomach Anatomy 0.000 description 3
- 238000012360 testing method Methods 0.000 description 3
- 206010011224 Cough Diseases 0.000 description 2
- 241000196324 Embryophyta Species 0.000 description 2
- 241000699670 Mus sp. Species 0.000 description 2
- 206010028980 Neoplasm Diseases 0.000 description 2
- 201000005702 Pertussis Diseases 0.000 description 2
- 206010037660 Pyrexia Diseases 0.000 description 2
- 241000191940 Staphylococcus Species 0.000 description 2
- 102000019197 Superoxide Dismutase Human genes 0.000 description 2
- 108010012715 Superoxide dismutase Proteins 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 235000009508 confectionery Nutrition 0.000 description 2
- 239000003085 diluting agent Substances 0.000 description 2
- 208000001848 dysentery Diseases 0.000 description 2
- RRAFCDWBNXTKKO-UHFFFAOYSA-N eugenol Chemical compound COC1=CC(CC=C)=CC=C1O RRAFCDWBNXTKKO-UHFFFAOYSA-N 0.000 description 2
- 235000013305 food Nutrition 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- 210000003734 kidney Anatomy 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 230000035790 physiological processes and functions Effects 0.000 description 2
- 231100000614 poison Toxicity 0.000 description 2
- ZMQAAUBTXCXRIC-UHFFFAOYSA-N safrole Chemical compound C=CCC1=CC=C2OCOC2=C1 ZMQAAUBTXCXRIC-UHFFFAOYSA-N 0.000 description 2
- 210000000952 spleen Anatomy 0.000 description 2
- 238000011282 treatment Methods 0.000 description 2
- KJPRLNWUNMBNBZ-QPJJXVBHSA-N (E)-cinnamaldehyde Chemical compound O=C\C=C\C1=CC=CC=C1 KJPRLNWUNMBNBZ-QPJJXVBHSA-N 0.000 description 1
- 239000001169 1-methyl-4-propan-2-ylcyclohexa-1,4-diene Substances 0.000 description 1
- MCSXGCZMEPXKIW-UHFFFAOYSA-N 3-hydroxy-4-[(4-methyl-2-nitrophenyl)diazenyl]-N-(3-nitrophenyl)naphthalene-2-carboxamide Chemical compound Cc1ccc(N=Nc2c(O)c(cc3ccccc23)C(=O)Nc2cccc(c2)[N+]([O-])=O)c(c1)[N+]([O-])=O MCSXGCZMEPXKIW-UHFFFAOYSA-N 0.000 description 1
- FRXSZNDVFUDTIR-UHFFFAOYSA-N 6-methoxy-1,2,3,4-tetrahydroquinoline Chemical compound N1CCCC2=CC(OC)=CC=C21 FRXSZNDVFUDTIR-UHFFFAOYSA-N 0.000 description 1
- 208000004998 Abdominal Pain Diseases 0.000 description 1
- 244000296912 Ageratum conyzoides Species 0.000 description 1
- 235000004405 Ageratum conyzoides Nutrition 0.000 description 1
- QGZKDVFQNNGYKY-UHFFFAOYSA-O Ammonium Chemical compound [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 description 1
- 239000004382 Amylase Substances 0.000 description 1
- 102000013142 Amylases Human genes 0.000 description 1
- 108010065511 Amylases Proteins 0.000 description 1
- 241000186000 Bifidobacterium Species 0.000 description 1
- 235000011293 Brassica napus Nutrition 0.000 description 1
- 240000008100 Brassica rapa Species 0.000 description 1
- 235000000540 Brassica rapa subsp rapa Nutrition 0.000 description 1
- 244000080208 Canella winterana Species 0.000 description 1
- 235000008499 Canella winterana Nutrition 0.000 description 1
- 235000016535 Capraria biflora Nutrition 0.000 description 1
- 206010007247 Carbuncle Diseases 0.000 description 1
- NPBVQXIMTZKSBA-UHFFFAOYSA-N Chavibetol Natural products COC1=CC=C(CC=C)C=C1O NPBVQXIMTZKSBA-UHFFFAOYSA-N 0.000 description 1
- 241000123847 Cinnamomum parthenoxylon Species 0.000 description 1
- 206010011469 Crying Diseases 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 206010013789 Dry throat Diseases 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 241000588724 Escherichia coli Species 0.000 description 1
- 239000005770 Eugenol Substances 0.000 description 1
- 208000015220 Febrile disease Diseases 0.000 description 1
- 208000005577 Gastroenteritis Diseases 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 235000017309 Hypericum perforatum Nutrition 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 241000699666 Mus <mouse, genus> Species 0.000 description 1
- 244000131316 Panax pseudoginseng Species 0.000 description 1
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 description 1
- 235000003140 Panax quinquefolius Nutrition 0.000 description 1
- 108091005804 Peptidases Proteins 0.000 description 1
- 102000003992 Peroxidases Human genes 0.000 description 1
- 241000219050 Polygonaceae Species 0.000 description 1
- 241001619461 Poria <basidiomycete fungus> Species 0.000 description 1
- 239000004365 Protease Substances 0.000 description 1
- UVMRYBDEERADNV-UHFFFAOYSA-N Pseudoeugenol Natural products COC1=CC(C(C)=C)=CC=C1O UVMRYBDEERADNV-UHFFFAOYSA-N 0.000 description 1
- 208000003100 Pseudomembranous Enterocolitis Diseases 0.000 description 1
- 206010037549 Purpura Diseases 0.000 description 1
- 241001672981 Purpura Species 0.000 description 1
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 description 1
- 206010053615 Thermal burn Diseases 0.000 description 1
- 206010043458 Thirst Diseases 0.000 description 1
- AXMVYSVVTMKQSL-UHFFFAOYSA-N UNPD142122 Natural products OC1=CC=C(C=CC=O)C=C1O AXMVYSVVTMKQSL-UHFFFAOYSA-N 0.000 description 1
- 208000031971 Yin Deficiency Diseases 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 235000019418 amylase Nutrition 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 230000003064 anti-oxidating effect Effects 0.000 description 1
- 230000003035 anti-peroxidant effect Effects 0.000 description 1
- 230000000840 anti-viral effect Effects 0.000 description 1
- 229930006722 beta-pinene Natural products 0.000 description 1
- 238000005842 biochemical reaction Methods 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 210000000481 breast Anatomy 0.000 description 1
- 238000009395 breeding Methods 0.000 description 1
- 230000001488 breeding effect Effects 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 230000000711 cancerogenic effect Effects 0.000 description 1
- 231100000357 carcinogen Toxicity 0.000 description 1
- 239000003183 carcinogenic agent Substances 0.000 description 1
- 235000013351 cheese Nutrition 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 208000013116 chronic cough Diseases 0.000 description 1
- 208000019902 chronic diarrheal disease Diseases 0.000 description 1
- 229940117916 cinnamic aldehyde Drugs 0.000 description 1
- KJPRLNWUNMBNBZ-UHFFFAOYSA-N cinnamic aldehyde Natural products O=CC=CC1=CC=CC=C1 KJPRLNWUNMBNBZ-UHFFFAOYSA-N 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 239000000084 colloidal system Substances 0.000 description 1
- 230000001276 controlling effect Effects 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 208000010643 digestive system disease Diseases 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 208000017574 dry cough Diseases 0.000 description 1
- 238000004043 dyeing Methods 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 229960002217 eugenol Drugs 0.000 description 1
- 230000007717 exclusion Effects 0.000 description 1
- 239000003172 expectorant agent Substances 0.000 description 1
- 230000003419 expectorant effect Effects 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 210000003608 fece Anatomy 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 210000001035 gastrointestinal tract Anatomy 0.000 description 1
- 235000008434 ginseng Nutrition 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 239000001963 growth medium Substances 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 230000023597 hemostasis Effects 0.000 description 1
- 230000007365 immunoregulation Effects 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 210000000867 larynx Anatomy 0.000 description 1
- -1 lipid peroxide Chemical class 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 201000007227 lymph node tuberculosis Diseases 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 150000002772 monosaccharides Chemical class 0.000 description 1
- GQPLMRYTRLFLPF-UHFFFAOYSA-N nitrous oxide Inorganic materials [O-][N+]#N GQPLMRYTRLFLPF-UHFFFAOYSA-N 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 108040007629 peroxidase activity proteins Proteins 0.000 description 1
- 150000007875 phellandrene derivatives Chemical class 0.000 description 1
- 239000002504 physiological saline solution Substances 0.000 description 1
- 230000007096 poisonous effect Effects 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 238000011321 prophylaxis Methods 0.000 description 1
- 239000002516 radical scavenger Substances 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 238000002791 soaking Methods 0.000 description 1
- 239000011550 stock solution Substances 0.000 description 1
- 230000004206 stomach function Effects 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 230000001629 suppression Effects 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
- 239000000341 volatile oil Substances 0.000 description 1
- 238000010792 warming Methods 0.000 description 1
- 235000013618 yogurt Nutrition 0.000 description 1
- WTARULDDTDQWMU-UHFFFAOYSA-N β-pinene Chemical compound C1C2C(C)(C)C1CCC2=C WTARULDDTDQWMU-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
- C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
- C08B37/0003—General processes for their isolation or fractionation, e.g. purification or extraction from biomass
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- General Health & Medical Sciences (AREA)
- Sustainable Development (AREA)
- Biochemistry (AREA)
- Materials Engineering (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Medicinal Chemistry (AREA)
- Polymers & Plastics (AREA)
- Organic Chemistry (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
本发明公开了用于改善肠胃功能的乳酸菌制剂,由下列原料制备而成,均为重量份:海藻多糖28‑40,活性乳酸菌干粉30‑46,阿拉伯糖4‑8,天冬5‑10,香樟8‑12,玄参3‑9,荞麦秸6‑9,小麦淀粉20‑40。本发明所得产品具有增强益生菌,抑制病原菌的功效,可提高机体免疫力,产品携带及食用方便,适宜人群广泛,具有良好的社会效益和经济效益。
Description
技术领域
本发明涉及一种保健品,具体是涉及一种用于改善肠胃功能的乳酸菌制剂及制备方法。
背景技术
海藻多糖是一类多组分的混合物,不仅具有清除活性氧的作用,还能够显着降低脂质过氧化物(LPO)的含量,提高过氧化物酶(CAT)和超氧化物歧化酶(SOD)的活性,具有清除过多自由基与抗脂质过氧化的作用,其生理功能包括免疫调节作用、抗病毒、抗氧化、抗肿瘤等。
活性乳酸菌是人体肠道正常菌群的主要微生物,对人体具有很多有益作用,包括排阻、抑制外来致病菌、提供维生素等营养,产生淀粉酶、蛋白酶等有助于消化的酶类,分解有毒或致癌物质(亚硝铵),产生有机酸、降低肠道pH和促进肠道的正常蠕动,刺激机体的免疫系统并提高免疫力。活性乳酸菌在肠道的大量繁殖,可以治疗伪膜性肠炎(因大量使用抗生素而导致),治疗慢性腹泻和便秘,降低胆固醇,预防癌症的发生。
阿拉伯糖是一种叫阿拉伯树分泌的胶体中经复杂的化学和物理方法分离提取出来的一种左旋单糖,其生理功能为可抑制蔗糖的代谢与吸收、控制血糖升高,抑制脂肪生成、预防便秘,促进双歧杆菌生长等。
公布号CN 103446552 A(申请号201210176435.2)的中国专利文献公开了一种健脾和胃中药复方提取物经肠道益生菌发酵,以提高和改善其预防和治疗消化系统疾病的方法。本发明进一步涉及麦芽、山楂、茯苓、陈皮、大枣、甘草、生姜、萝卜提取物经肠道益生菌发酵后制得的发酵组合物。公布号CN 103830279 A(申请号201310736926.2)的中国专利文献公开了一种富硒乳酸菌制剂生产方法及其富硒乳酸菌制剂,其主要成分是富含有机硒的乳酸菌,所说的有机硒是通过乳酸菌发酵转化无机硒而富集在菌体内,每克制剂中硒含量为4-12 毫克。公布号CN 102630749 A(申请号201210133705.1)的中国专利文献公开了一种灵芝白灵菇酸奶的制备方法,是在牛乳中添加灵芝发酵液和白灵菇发酵液发酵而成 ;所述的灵芝发酵液和白灵菇发酵液与牛乳的比例为 1:5( 质量比) ;其中灵芝发酵液与白灵菇发酵液的比例为 2.25:1( 质量比);所述的灵芝发酵液和白灵菇发酵液由灵芝和白灵菇菌种发酵培养而成。
发明内容
本发明的目的是提供一种用于改善肠胃功能的乳酸菌制剂及制备方法,可改善人体肠道功能,提高身体免疫力。
本发明的方案为:
用于改善肠胃功能的乳酸菌制剂,由下列原料制备而成,均为重量份:海藻多糖28-40,活性乳酸菌干粉30-46,阿拉伯糖4-8,天冬5-10,香樟8-12,玄参3-9,荞麦秸6-9,小麦淀粉20-40。
优选方案为,海藻多糖32-36,活性乳酸菌干粉34-42,阿拉伯糖5-7,天冬6-9,香樟9-11,玄参5-7,荞麦秸7-8,小麦淀粉25-35。
更加优选的是,海藻多糖34,活性乳酸菌干粉38,阿拉伯糖6,天冬7.5,香樟10,玄参6,荞麦秸7.5,小麦淀粉30。
所述的乳酸菌制剂的制备方法,步骤如下:
(1)海藻多糖的制备:
A.取净制的海藻干燥,碾碎,加入10-14倍的质量浓度90%的乙醇溶液浸泡20-36h(优选的:加入11-13倍的质量浓度90%的乙醇溶液浸泡24-32h;更加优选的:加入12倍的质量浓度90%的乙醇溶液浸泡28h),离心15min,晾干得预处理料;
B.将预处理料置于蒸馏水中,蒸馏水与预处理料的比为25-35 mL/g(v/w),加热至80-100℃提取1.5-2.5h(优选的:加热至85-95℃提取1.8-2.2h;更加优选的:加热至90℃提取2h),用100-150目纱布过滤,滤渣重复提取3次;
C.将步骤B中多次提取的多糖溶液混合,采用超滤膜分子量为1万的中空纤维素膜进行超滤,去除1万以下的小分子物质;
D.在超滤后的提取液中加入无水乙醇,直至溶液的乙醇终点浓度为70~95%(优选的,加无水乙醇直至溶液终点浓度为80-85%,更加优选的,加无水乙醇直至溶液终点浓度为83%),4℃静置24 h,离心,取沉淀部分,置于-20℃下3 h,然后转入-80℃下冷冻12h,然后转入真空冷冻干燥机干燥,得海藻多糖;
(2)活性乳酸菌干粉的制备:
A.取原料奶加热至55-65℃(优选的:加热至60℃),加入0.1%黄原胶和8%白砂糖等辅料,搅拌至均匀;
B.将步骤A配好的料液在15-35Mpa、55-70℃ 条件下进行均质(优选的:在20-30 Mpa、60-65℃ 条件下进行均质;更加优选的:在25 Mpa、63℃ 条件下进行均质);
C.将均质后的料液置于95℃状态下,持续8 min,然后冷却至40℃~48℃(优选的:冷却至44℃),按照发酵体积4%-8%的量接种复合菌剂,置于43℃下恒温培养5-9h(优选的:恒温培养6-8h;更加优选的:恒温培养7h),待酸度达到75°T 时,将产品降温至4℃下冷藏后熟15-25h(优选的:冷藏后熟20h),得到凝乳状酸牛乳;
D.将所得凝乳状酸牛乳用55℃喷雾干燥器干燥粉碎,制成活性乳酸菌干粉;
(3)制备成品:
A.取天冬、香樟、玄参和荞麦秸洗净除杂,加入浓度20%的食盐水浸泡10-20分钟(优选的:浸泡13-17分钟;更加优选的:浸泡15分钟),取出置于烤箱内,115℃下恒温烘干15分钟,取出粉碎过80-160目筛,制成粉末;
B.将步骤A所得粉末与阿拉伯糖和小麦淀粉混合,再加入步骤(1)(2)所得海藻多糖和活性乳酸菌干粉,搅拌20min,装填入胶囊内,制成胶囊剂。
所述的乳酸菌制剂的制备方法,步骤(1)蒸馏水与预处理料的比为28-32mL/g(v/w)(优选的:蒸馏水与预处理料的比为30 mL/g)。
所述的乳酸菌制剂的制备方法,步骤(1)用110-140目纱布过滤(优选的:用125目纱布过滤)。
所述的乳酸菌制剂的制备方法,步骤(2)复合菌剂为德氏乳杆菌、双歧杆菌和干酪乳杆菌按照1:1:1的质量比混合而成。
所述的乳酸菌制剂的制备方法,步骤(2)接种复合菌剂的量为发酵体积的5%-7%(优选的:接种复合菌剂的量为发酵体积的6%)。
所述的乳酸菌制剂的制备方法,步骤(3)加食盐水浸泡13-17分钟(优选的:加食盐水浸泡15分钟)。
所述的乳酸菌制剂的制备方法,步骤(3)取出粉碎过100-140目筛(优选的:取出粉碎过120目筛)。
本发明产品制备简单,服用方便,;除此之外,本发明的优良效果还表现在:
(1)本发明将海藻多糖、阿拉伯糖与中药成分相结合,保证有效成分的合理利用;
(2)本发明产品携带方便,适宜人群广泛,对于改善肠道功能效果甚佳,具有良好的社会效益和经济效益。
具体实施方式
下面结合实施例和实验例详细说明本发明的技术方案,但保护范围不限于此。
实施例1 用于改善肠胃功能的乳酸菌制剂,由下列原料制备而成(每份1kg):海藻多糖28份,活性乳酸菌干粉30份,阿拉伯糖4份,天冬5份,香樟8份,玄参3份,荞麦秸6份,小麦淀粉20份。上述用于改善肠胃功能的乳酸菌制剂的制备方法是:
(1)海藻多糖的制备:
A.取净制的海藻干燥,碾碎,加入10倍的质量浓度90%的乙醇溶液浸泡20-36h,离心15min,晾干得预处理料;
B.将预处理料置于蒸馏水中,蒸馏水与预处理料的比为25mL/g(v/w),加热至80℃提取1.5h,用100目纱布过滤,滤渣重复提取3次;
C.将步骤B中多次提取的多糖溶液混合,采用超滤膜分子量为1万的中空纤维素膜进行超滤,去除1万以下的小分子物质;
D.在超滤后的提取液中加入无水乙醇,直至溶液的乙醇终点浓度为70%,4℃静置24 h,离心,取沉淀部分,置于-20℃下3 h,然后转入-80℃下冷冻12h,然后转入真空冷冻干燥机干燥,得海藻多糖;
(2)活性乳酸菌干粉的制备:
A.取原料奶加热至55℃,加入0.1%黄原胶和8%白砂糖等辅料,搅拌至均匀;
B.将步骤A配好的料液在15Mpa、55℃ 条件下进行均质;
C.将均质后的料液置于95℃状态下,持续8 min,然后冷却至40℃,按照发酵体积4%的量接种复合菌剂,复合菌剂为德氏乳杆菌、双歧杆菌和干酪乳杆菌按照1:1:1的质量比混合而成,置于43℃下恒温培养5h,待酸度达到75°T 时,将产品降温至4℃下冷藏后熟15h,得到凝乳状酸牛乳;
D.将所得凝乳状酸牛乳用55℃喷雾干燥器干燥粉碎,制成活性乳酸菌干粉;
(3)制备成品:
A.取天冬、香樟、玄参和荞麦秸洗净除杂,加入浓度20%的食盐水浸泡10分钟,取出置于烤箱内,115℃下恒温烘干15分钟,取出粉碎过80目筛,制成粉末;
B.将步骤A所得粉末与阿拉伯糖和小麦淀粉混合,再加入步骤(1)(2)所得海藻多糖和活性乳酸菌干粉,搅拌20min,装填入胶囊内,制成胶囊剂。
实施例2用于改善肠胃功能的乳酸菌制剂,由下列原料制备而成(每份1kg):海藻多糖40份,活性乳酸菌干粉46份,阿拉伯糖8份,天冬10份,香樟12份,玄参9份,荞麦秸9份,小麦淀粉40份。上述用于改善肠胃功能的乳酸菌制剂的制备方法是:
(1)海藻多糖的制备:
A.取净制的海藻干燥,碾碎,加入14倍的质量浓度90%的乙醇溶液浸泡36h,离心15min,晾干得预处理料;
B.将预处理料置于蒸馏水中,蒸馏水与预处理料的比为35 mL/g(v/w),加热至100℃提取2.5h,用150目纱布过滤,滤渣重复提取3次;
C.将步骤B中多次提取的多糖溶液混合,采用超滤膜分子量为1万的中空纤维素膜进行超滤,去除1万以下的小分子物质;
D.在超滤后的提取液中加入无水乙醇,直至溶液的乙醇终点浓度为95%,4℃静置24 h,离心,取沉淀部分,置于-20℃下3 h,然后转入-80℃下冷冻12h,然后转入真空冷冻干燥机干燥,得海藻多糖;
(2)活性乳酸菌干粉的制备:
A.取原料奶加热至65℃,加入0.1%黄原胶和8%白砂糖等辅料,搅拌至均匀;
B.将步骤A配好的料液在35Mpa、70℃ 条件下进行均质;
C.将均质后的料液置于95℃状态下,持续8 min,然后冷却至48℃,按照发酵体积8%的量接种复合菌剂,复合菌剂为德氏乳杆菌、双歧杆菌和干酪乳杆菌按照1:1:1的质量比混合而成,置于43℃下恒温培养9h,待酸度达到75°T 时,将产品降温至4℃下冷藏后熟25h,得到凝乳状酸牛乳;
D.将所得凝乳状酸牛乳用55℃喷雾干燥器干燥粉碎,制成活性乳酸菌干粉;
(3)制备成品:
A.取天冬、香樟、玄参和荞麦秸洗净除杂,加入浓度20%的食盐水浸泡20分钟,取出置于烤箱内,115℃下恒温烘干15分钟,取出粉碎过160目筛,制成粉末;
B.将步骤A所得粉末与阿拉伯糖和小麦淀粉混合,再加入步骤(1)(2)所得海藻多糖和活性乳酸菌干粉,搅拌20min,装填入胶囊内,制成胶囊剂。
实施例3用于改善肠胃功能的乳酸菌制剂,由下列原料制备而成(每份1kg):海藻多糖32份,活性乳酸菌干粉34份,阿拉伯糖5份,天冬6份,香樟9份,玄参5份,荞麦秸7份,小麦淀粉25份。上述用于改善肠胃功能的乳酸菌制剂的制备方法是:
(1)海藻多糖的制备:
A.取净制的海藻干燥,碾碎,加入11倍的质量浓度90%的乙醇溶液浸泡24h,离心15min,晾干得预处理料;
B.将预处理料置于蒸馏水中,蒸馏水与预处理料的比为28 mL/g(v/w),加热至85℃提取1.8h,用110目纱布过滤,滤渣重复提取3次;
C.将步骤B中多次提取的多糖溶液混合,采用超滤膜分子量为1万的中空纤维素膜进行超滤,去除1万以下的小分子物质;
D.在超滤后的提取液中加入无水乙醇,直至溶液的乙醇终点浓度为80%,4℃静置24 h,离心,取沉淀部分,置于-20℃下3 h,然后转入-80℃下冷冻12h,然后转入真空冷冻干燥机干燥,得海藻多糖;
(2)活性乳酸菌干粉的制备:
A.取原料奶加热至55℃,加入0.1%黄原胶和8%白砂糖等辅料,搅拌至均匀;
B.将步骤A配好的料液在20Mpa、60℃ 条件下进行均质;
C.将均质后的料液置于95℃状态下,持续8 min,然后冷却至40℃,按照发酵体积5%的量接种复合菌剂,复合菌剂为德氏乳杆菌、双歧杆菌和干酪乳杆菌按照1:1:1的质量比混合而成,置于43℃下恒温培养6h,待酸度达到75°T 时,将产品降温至4℃下冷藏后熟15h,得到凝乳状酸牛乳;
D.将所得凝乳状酸牛乳用55℃喷雾干燥器干燥粉碎,制成活性乳酸菌干粉;
(3)制备成品:
A.取天冬、香樟、玄参和荞麦秸洗净除杂,加入浓度20%的食盐水浸泡13分钟,取出置于烤箱内,115℃下恒温烘干15分钟,取出粉碎过100目筛,制成粉末;
B.将步骤A所得粉末与阿拉伯糖和小麦淀粉混合,再加入步骤(1)(2)所得海藻多糖和活性乳酸菌干粉,搅拌20min,装填入胶囊内,制成胶囊剂。
实施例4用于改善肠胃功能的乳酸菌制剂,由下列原料制备而成(每份1kg):海藻多糖36份,活性乳酸菌干粉42份,阿拉伯糖7份,天冬9份,香樟11份,玄参7份,荞麦秸8份,小麦淀粉35份。上述用于改善肠胃功能的乳酸菌制剂的制备方法是:
(1)海藻多糖的制备:
A.取净制的海藻干燥,碾碎,加入13倍的质量浓度90%的乙醇溶液浸泡32h,离心15min,晾干得预处理料;
B.将预处理料置于蒸馏水中,蒸馏水与预处理料的比为32 mL/g(v/w),加热至95℃提取2.2h,用140目纱布过滤,滤渣重复提取3次;
C.将步骤B中多次提取的多糖溶液混合,采用超滤膜分子量为1万的中空纤维素膜进行超滤,去除1万以下的小分子物质;
D.在超滤后的提取液中加入无水乙醇,直至溶液的乙醇终点浓度为85%,4℃静置24 h,离心,取沉淀部分,置于-20℃下3 h,然后转入-80℃下冷冻12h,然后转入真空冷冻干燥机干燥,得海藻多糖;
(2)活性乳酸菌干粉的制备:
A.取原料奶加热至65℃,加入0.1%黄原胶和8%白砂糖等辅料,搅拌至均匀;
B.将步骤A配好的料液在30Mpa、65℃ 条件下进行均质;
C.将均质后的料液置于95℃状态下,持续8 min,然后冷却至48℃,按照发酵体积7%的量接种复合菌剂,复合菌剂为德氏乳杆菌、双歧杆菌和干酪乳杆菌按照1:1:1的质量比混合而成,置于43℃下恒温培养8h,待酸度达到75°T 时,将产品降温至4℃下冷藏后熟25h,得到凝乳状酸牛乳;
D.将所得凝乳状酸牛乳用55℃喷雾干燥器干燥粉碎,制成活性乳酸菌干粉;
(3)制备成品:
A.取天冬、香樟、玄参和荞麦秸洗净除杂,加入浓度20%的食盐水浸泡17分钟,取出置于烤箱内,115℃下恒温烘干15分钟,取出粉碎过140目筛,制成粉末;
B.将步骤A所得粉末与阿拉伯糖和小麦淀粉混合,再加入步骤(1)(2)所得海藻多糖和活性乳酸菌干粉,搅拌20min,装填入胶囊内,制成胶囊剂。
实施例5用于改善肠胃功能的乳酸菌制剂,由下列原料制备而成(每份1kg):海藻多糖34份,活性乳酸菌干粉38份,阿拉伯糖6份,天冬7.5份,香樟10份,玄参6份,荞麦秸7.5份,小麦淀粉30份。上述用于改善肠胃功能的乳酸菌制剂的制备方法是:
(1)海藻多糖的制备:
A.取净制的海藻干燥,碾碎,加入12倍的质量浓度90%的乙醇溶液浸泡28h,离心15min,晾干得预处理料;
B.将预处理料置于蒸馏水中,蒸馏水与预处理料的比为30 mL/g(v/w),加热至90℃提取2h,用125目纱布过滤,滤渣重复提取3次;
C.将步骤B中多次提取的多糖溶液混合,采用超滤膜分子量为1万的中空纤维素膜进行超滤,去除1万以下的小分子物质;
D.在超滤后的提取液中加入无水乙醇,直至溶液的乙醇终点浓度为83%,4℃静置24 h,离心,取沉淀部分,置于-20℃下3 h,然后转入-80℃下冷冻12h,然后转入真空冷冻干燥机干燥,得海藻多糖;
(2)活性乳酸菌干粉的制备:
A.取原料奶加热至60℃,加入0.1%黄原胶和8%白砂糖等辅料,搅拌至均匀;
B.将步骤A配好的料液在25Mpa、63℃ 条件下进行均质;
C.将均质后的料液置于95℃状态下,持续8 min,然后冷却至44℃,按照发酵体积6%的量接种复合菌剂,复合菌剂为德氏乳杆菌、双歧杆菌和干酪乳杆菌按照1:1:1的质量比混合而成,置于43℃下恒温培养7h,待酸度达到75°T 时,将产品降温至4℃下冷藏后熟20h,得到凝乳状酸牛乳;
D.将所得凝乳状酸牛乳用55℃喷雾干燥器干燥粉碎,制成活性乳酸菌干粉;
(3)制备成品:
A.取天冬、香樟、玄参和荞麦秸洗净除杂,加入浓度20%的食盐水浸泡15分钟,取出置于烤箱内,115℃下恒温烘干15分钟,取出粉碎过120目筛,制成粉末;
B.将步骤A所得粉末与阿拉伯糖和小麦淀粉混合,再加入步骤(1)(2)所得海藻多糖和活性乳酸菌干粉,搅拌20min,装填入胶囊内,制成胶囊剂。
本发明所用原料:
天冬:基源:为百合科植物天门冬的干燥块根。性味:甘、苦,寒。归经:归肺、肾经。功能主治:养阴润燥,清肺生津。用于肺燥干咳,顿咳痰黏,咽干口渴,肠燥便秘。
香樟:基源:为樟科植物黄樟的根或茎。化学成份:树干和树根含挥发油2~4%,油中主要成分为黄樟醚,含量达60~95%,其次为β-蒎烯、水芹烯、丁香油酚和桂皮醛等。性味:微辛,温。功能主治:温中散寒,消食化滞。治胃肠炎,胃寒腹痛,消化不良,百日咳,痢疾。
玄参:基源:为玄参科植物玄参及北玄参的根。性味:味甘;苦;咸;性微寒。归经:归肺;胃;肾经。功能主治:清热凉血;滋阴降火;解毒散结。主温热病热和营血;身热;烦渴;舌绛;发斑;骨蒸劳嗽;虚烦不寤;津伤便秘;目涩昏花;咽喉喉肿痛;瘰疬痰核;痈疽疮毒。
荞麦秸:基源:为蓼科植物荞麦的茎叶。性味:酸;性寒。功能主治:下气消积;清热解毒;止血;降压。主噎食;消化不良;痢疾;白带;痈肿;烫伤;咯血;紫癜;高血压;糖尿病并发现网膜炎。
试验例1 本发明所得用于改善肠胃功能的乳酸菌制剂(实施例5)的临床试验:
选取清洁级雄性小鼠40只,体重均在60-68g,随机分为三组,空白组10只、对照组15只和实验组15只,其中空白组用蒸馏水连续灌胃14d,对照组用本发明所得产品配置的浓度为0.5g/ml的稀释液连续灌胃14d,实验组用本发明所得产品配置的浓度为1.5g/ml的稀释液连续灌胃14d,三组样品灌服的体积均按照0.5ml/20g小鼠体重的标准进行。
在给予受试动物之前,无菌采取小鼠粪便0.1g左右,加入无菌生理盐水,电动搅拌均匀,10倍稀释至10-8,从原液中吸取1ml置于培养基内,恒温37℃培养,培养后,以菌落形态、格兰染色、生化反应等鉴定计数菌落,计算出每克湿便中的菌数,取对数后进行统计处理;最后一次给予受试物之后的24h,无菌采取粪便,检查肠道菌群,方法同上。
试验结果如表1所示:
表1 肠道菌群检测结果(Log(CFU/g))
由表1可知,灌服前,三组中每克湿便所含的大肠杆菌、葡萄球菌、乳酸杆菌及双歧杆菌菌落数,差异无显著性,灌服后,实验组中双歧杆菌的数量显著高于灌服前,且葡萄球菌及大肠杆菌的含量较灌服前有所下降,说明本发明所得产品可促进肠道菌群,促进有益菌的繁殖及生长,进而改善肠胃功能。
应当指出的是,具体实施方式只是本发明比较有代表性的例子,显然本发明的技术方案不限于上述实施例,还可以有很多变形。本领域的普通技术人员,以本发明所明确公开的或根据文件的书面描述毫无异议的得到的,均应认为是本专利所要保护的范围。
Claims (10)
1.用于改善肠胃功能的乳酸菌制剂,其特征在于,由下列原料制备而成,均为重量份:海藻多糖28-40,活性乳酸菌干粉30-46,阿拉伯糖4-8,天冬5-10,香樟8-12,玄参3-9,荞麦秸6-9,小麦淀粉20-40。
2.根据权利要求1 所述的乳酸菌制剂,其特征在于,海藻多糖32-36,活性乳酸菌干粉34-42,阿拉伯糖5-7,天冬6-9,香樟9-11,玄参5-7,荞麦秸7-8,小麦淀粉25-35。
3.根据权利要求1 所述的乳酸菌制剂,其特征在于,海藻多糖34,活性乳酸菌干粉38,阿拉伯糖6,天冬7.5,香樟10,玄参6,荞麦秸7.5,小麦淀粉30。
4.根据权利要求1-3任一所述的乳酸菌制剂的制备方法,其特征在于,步骤如下:
(1)海藻多糖的制备:
A.取净制的海藻干燥,碾碎,加入10-14倍的质量浓度90%的乙醇溶液浸泡20-36h(优选的:加入11-13倍的质量浓度90%的乙醇溶液浸泡24-32h;更加优选的:加入12倍的质量浓度90%的乙醇溶液浸泡28h),离心15min,晾干得预处理料;
B.将预处理料置于蒸馏水中,蒸馏水与预处理料的比为25-35 mL/g(v/w),加热至80-100℃提取1.5-2.5h(优选的:加热至85-95℃提取1.8-2.2h;更加优选的:加热至90℃提取2h),用100-150目纱布过滤,滤渣重复提取3次;
C.将步骤B中多次提取的多糖溶液混合,采用超滤膜分子量为1万的中空纤维素膜进行超滤,去除1万以下的小分子物质;
D.在超滤后的提取液中加入无水乙醇,直至溶液的乙醇终点浓度为70~95%(优选的,加无水乙醇直至溶液终点浓度为80-85%,更加优选的,加无水乙醇直至溶液终点浓度为83%),4℃静置24 h,离心,取沉淀部分,置于-20℃下3 h,然后转入-80℃下冷冻12h,然后转入真空冷冻干燥机干燥,得海藻多糖;
(2)活性乳酸菌干粉的制备:
A.取原料奶加热至55-65℃(优选的:加热至60℃),加入0.1%黄原胶和8%白砂糖等辅料,搅拌至均匀;
B.将步骤A配好的料液在15-35Mpa、55-70℃ 条件下进行均质(优选的:在20-30 Mpa、60-65℃ 条件下进行均质;更加优选的:在25 Mpa、63℃ 条件下进行均质);
C.将均质后的料液置于95℃状态下,持续8 min,然后冷却至40℃~48℃(优选的:冷却至44℃),按照发酵体积4%-8%的量接种复合菌剂,置于43℃下恒温培养5-9h(优选的:恒温培养6-8h;更加优选的:恒温培养7h),待酸度达到75°T 时,将产品降温至4℃下冷藏后熟15-25h(优选的:冷藏后熟20h),得到凝乳状酸牛乳;
D.将所得凝乳状酸牛乳用55℃喷雾干燥器干燥粉碎,制成活性乳酸菌干粉;
(3)制备成品:
A.取天冬、香樟、玄参和荞麦秸洗净除杂,加入浓度20%的食盐水浸泡10-20分钟,取出置于烤箱内,115℃下恒温烘干15分钟,取出粉碎过80-160目筛,制成粉末;
B.将步骤A所得粉末与阿拉伯糖和小麦淀粉混合,再加入步骤(1)(2)所得海藻多糖和活性乳酸菌干粉,搅拌20min,装填入胶囊内,制成胶囊剂。
5.根据权利要求4所述的乳酸菌制剂的制备方法,其特征在于,步骤(1)蒸馏水与预处理料的比为28-32mL/g(v/w)(优选的:蒸馏水与预处理料的比为30 mL/g)。
6.根据权利要求4所述的乳酸菌制剂的制备方法,其特征在于,步骤(1)用110-140目纱布过滤(优选的:用125目纱布过滤)。
7.根据权利要求4 所述的乳酸菌制剂的制备方法,其特征在于,步骤(2)复合菌剂为德氏乳杆菌、双歧杆菌和干酪乳杆菌按照1:1:1的质量比混合而成。
8.根据权利要求4 所述的乳酸菌制剂的制备方法,其特征在于,步骤(2)接种复合菌剂的量为发酵体积的5%-7%(优选的:接种复合菌剂的量为发酵体积的6%)。
9.根据权利要求4 所述的乳酸菌制剂的制备方法,其特征在于,步骤(3)加食盐水浸泡13-17分钟(优选的:加食盐水浸泡15分钟)。
10.根据权利要求4 所述的乳酸菌制剂的制备方法,其特征在于,步骤(3)取出粉碎过100-140目筛(优选的:取出粉碎过120目筛)。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610312048.5A CN105996050A (zh) | 2016-05-12 | 2016-05-12 | 用于改善肠胃功能的乳酸菌制剂及制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610312048.5A CN105996050A (zh) | 2016-05-12 | 2016-05-12 | 用于改善肠胃功能的乳酸菌制剂及制备方法 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN105996050A true CN105996050A (zh) | 2016-10-12 |
Family
ID=57099276
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201610312048.5A Pending CN105996050A (zh) | 2016-05-12 | 2016-05-12 | 用于改善肠胃功能的乳酸菌制剂及制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN105996050A (zh) |
Citations (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1923042A (zh) * | 2005-08-29 | 2007-03-07 | 李伟 | 一种新型保健食品 |
CN101189982A (zh) * | 2006-11-27 | 2008-06-04 | 郑慧娣 | 含有海藻多糖和双歧杆菌的酸奶 |
CN101810845A (zh) * | 2009-02-20 | 2010-08-25 | 黄刚 | 增强免疫力修复胃肠功能保护心脑肝肾细胞的营养剂 |
CN101953916A (zh) * | 2010-09-13 | 2011-01-26 | 杜丹 | 一种含嗜酸乳杆菌和中药的组合物及其应用 |
CN102106925A (zh) * | 2009-12-28 | 2011-06-29 | 于莲 | 枸杞多糖双歧杆菌合生元结肠靶向微生态调节剂 |
CN104045725A (zh) * | 2014-06-25 | 2014-09-17 | 聊城大学 | 采用d301g阴离子树脂精制桦褐孔菌粗多糖的方法 |
CN103190479B (zh) * | 2012-12-26 | 2014-12-03 | 光明乳业股份有限公司 | 一种酸奶粉、酸奶冰淇淋粉及其制备方法和使用方法 |
CN104710541A (zh) * | 2015-03-31 | 2015-06-17 | 广西还珠海洋生物科技有限公司 | 一种从海带中制备海带多糖的方法 |
-
2016
- 2016-05-12 CN CN201610312048.5A patent/CN105996050A/zh active Pending
Patent Citations (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1923042A (zh) * | 2005-08-29 | 2007-03-07 | 李伟 | 一种新型保健食品 |
CN101189982A (zh) * | 2006-11-27 | 2008-06-04 | 郑慧娣 | 含有海藻多糖和双歧杆菌的酸奶 |
CN101810845A (zh) * | 2009-02-20 | 2010-08-25 | 黄刚 | 增强免疫力修复胃肠功能保护心脑肝肾细胞的营养剂 |
CN102106925A (zh) * | 2009-12-28 | 2011-06-29 | 于莲 | 枸杞多糖双歧杆菌合生元结肠靶向微生态调节剂 |
CN101953916A (zh) * | 2010-09-13 | 2011-01-26 | 杜丹 | 一种含嗜酸乳杆菌和中药的组合物及其应用 |
CN103190479B (zh) * | 2012-12-26 | 2014-12-03 | 光明乳业股份有限公司 | 一种酸奶粉、酸奶冰淇淋粉及其制备方法和使用方法 |
CN104045725A (zh) * | 2014-06-25 | 2014-09-17 | 聊城大学 | 采用d301g阴离子树脂精制桦褐孔菌粗多糖的方法 |
CN104710541A (zh) * | 2015-03-31 | 2015-06-17 | 广西还珠海洋生物科技有限公司 | 一种从海带中制备海带多糖的方法 |
Non-Patent Citations (2)
Title |
---|
关玉斌等: "活性酸奶片的研制与生产", 《食品工业科技》 * |
郭养浩: "《药物生物技术》", 30 November 2005, 高等教育出版社 * |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102132796B (zh) | 一种22-42日龄肉鸭饲料及其制备方法 | |
CN104351586A (zh) | 一种牛配合饲料及其制备方法 | |
CN102940155B (zh) | 一种樱桃谷鸭的雏鸭饲料及其制备方法 | |
CN103585433B (zh) | 一种治疗口腔溃疡的中药组合物 | |
CN102845638A (zh) | 一种防治禽流感的鸭饲料及其中药添加剂 | |
CN106266898A (zh) | 一种益气补肾、抗衰老的复方制剂及其制备方法 | |
CN105410346A (zh) | 提高养殖对虾存活率的中药制剂及其制备方法 | |
CN105685620A (zh) | 一种辣木口服液及其制备方法 | |
KR20160119999A (ko) | 동의보감 원문에 근거한 국산 유기농 공진단 및 이의 제조방법 | |
CN106173450A (zh) | 提高鸽子免疫力的复方饲料添加剂及饲料 | |
CN111700142B (zh) | 一种发酵茯苓酸代用茶的制备方法 | |
CN103518878B (zh) | 一种润肠健胃蜂蜜醋饮料以及制备方法 | |
CN105056159A (zh) | 一种治疗猪寄生虫病的药物及其制备方法 | |
CN102872321B (zh) | 一种防治猪蓝耳病的中药制剂及其制备方法 | |
CN104489265A (zh) | 一种治疗潮湿型鸡痘的配合饲料及其制备方法 | |
CN103977372A (zh) | 一种用于治疗猪流行性腹泻的中药添加剂及其制备方法 | |
CN106107100A (zh) | 羊体增膘用饲料添加剂及其制备方法 | |
CN105395674A (zh) | 一种防治禽腺肌胃炎的中药益生菌复合制剂及其制备方法 | |
CN105996050A (zh) | 用于改善肠胃功能的乳酸菌制剂及制备方法 | |
CN105749099A (zh) | 一种治疗胃癌的益生菌发酵中药组合物及其制备方法和应用 | |
CN106135667A (zh) | 一种可替代抗生素的畜禽用风味草本植物饲料添加剂及其制备方法 | |
CN102293883B (zh) | 治疗儿童急性上呼吸道感染的中药组合物及其制备方法与应用 | |
CN107095296B (zh) | 富硒红枣枸杞姜汤制作方法 | |
CN104222293A (zh) | 一种补气酸奶口嚼片及其生产方法 | |
CN110025782A (zh) | 一种抗幽门螺旋杆菌的中药组合物及其制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
CB02 | Change of applicant information |
Address after: 839000 the Xinjiang Uygur Autonomous Region, Hami, Tianshan Road, No. 65, building No. 2, No. 602, No. Applicant after: Li Hao Address before: Huaiyin District of Ji'nan City, Shandong province 250000 Ji Qi Road No. 112 Applicant before: Li Hao |
|
CB02 | Change of applicant information | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20161012 |
|
RJ01 | Rejection of invention patent application after publication |